Post by Monte Rosa Therapeutics

Today, Chief Medical Officer Filip Janku shares updates on Monte Rosa's clinical pipeline and continued momentum across our molecular glue degrader programs in a fireside chat at the Jefferies Global Healthcare Conference in New York. Tune in to learn more: https://bit.ly/3RNZVDh